[HTML][HTML] Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming

NR Mahadevan, V Anufreichik, JJ Rodvold, KT Chiu… - PloS one, 2012 - journals.plos.org
NR Mahadevan, V Anufreichik, JJ Rodvold, KT Chiu, H Sepulveda, M Zanetti
PloS one, 2012journals.plos.org
Tumor-infiltrating myeloid cells, such as dendritic cells (BMDC), are key regulators of tumor
growth. However, the tumor-derived signals polarizing BMDC to a phenotype that subverts
cell-mediated anti-tumor immunity have yet to be fully elucidated. Addressing this
unresolved problem we show that the tumor unfolded protein response (UPR) can function
in a cell-extrinsic manner via the transmission of ER stress (TERS) to BMDC. TERS-
imprinted BMDC upregulate the production of pro-inflammatory, tumorigenic cytokines but …
Tumor-infiltrating myeloid cells, such as dendritic cells (BMDC), are key regulators of tumor growth. However, the tumor-derived signals polarizing BMDC to a phenotype that subverts cell-mediated anti-tumor immunity have yet to be fully elucidated. Addressing this unresolved problem we show that the tumor unfolded protein response (UPR) can function in a cell-extrinsic manner via the transmission of ER stress (TERS) to BMDC. TERS-imprinted BMDC upregulate the production of pro-inflammatory, tumorigenic cytokines but also the immunosuppressive enzyme arginase. Importantly, they downregulate cross-presentation of high-affinity antigen and fail to effectively cross-prime CD8+ T cells, causing T cell activation without proliferation and similarly dominantly suppress cross-priming by bystander BMDC. Lastly, TERS-imprinted BMDC facilitate tumor growth in vivo with fewer tumor-infiltrating CD8+ T cells. In sum, we demonstrate that tumor-borne ER stress imprints ab initio BMDC to a phenotype that recapitulates several of the inflammatory/suppressive characteristics ascribed to tumor-infiltrating myeloid cells, highlighting the tumor UPR as a critical controller of anti-tumor immunity and a new target for immune modulation in cancer.
PLOS